CYCN logo

Cyclerion Therapeutics (CYCN)

Profile

Full Name

Cyclerion Therapeutics, Inc.

Ticker Symbol

CYCN

Exchange

NASDAQ

Country

United States

IPO

March 18, 2019

Indexes

Not included

Employees

1

Key Details

Price

$2.68(-0.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.00M

Annual EPS

-$1.21(+46.22% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Oct 20, 21 Truist Securities
Buy
Sep 24, 21 Cantor Fitzgerald
Overweight

Institutional Ownership

  • What is the ticker symbol for Cyclerion Therapeutics?
  • Does Cyclerion Therapeutics pay dividends?
  • What sector is Cyclerion Therapeutics in?
  • What industry is Cyclerion Therapeutics in?
  • What country is Cyclerion Therapeutics based in?
  • When did Cyclerion Therapeutics go public?
  • Is Cyclerion Therapeutics in the S&P 500?
  • Is Cyclerion Therapeutics in the NASDAQ 100?
  • Is Cyclerion Therapeutics in the Dow Jones?
  • When was Cyclerion Therapeutics's last earnings report?
  • When does Cyclerion Therapeutics report earnings?
  • Should I buy Cyclerion Therapeutics stock now?

What is the ticker symbol for Cyclerion Therapeutics?

The ticker symbol for Cyclerion Therapeutics is NASDAQ:CYCN

Does Cyclerion Therapeutics pay dividends?

No, Cyclerion Therapeutics does not pay dividends

What sector is Cyclerion Therapeutics in?

Cyclerion Therapeutics is in the Healthcare sector

What industry is Cyclerion Therapeutics in?

Cyclerion Therapeutics is in the Biotechnology industry

What country is Cyclerion Therapeutics based in?

Cyclerion Therapeutics is headquartered in United States

When did Cyclerion Therapeutics go public?

Cyclerion Therapeutics's initial public offering (IPO) was on March 18, 2019

Is Cyclerion Therapeutics in the S&P 500?

No, Cyclerion Therapeutics is not included in the S&P 500 index

Is Cyclerion Therapeutics in the NASDAQ 100?

No, Cyclerion Therapeutics is not included in the NASDAQ 100 index

Is Cyclerion Therapeutics in the Dow Jones?

No, Cyclerion Therapeutics is not included in the Dow Jones index

When was Cyclerion Therapeutics's last earnings report?

Cyclerion Therapeutics's most recent earnings report was on Nov 14, 2024

When does Cyclerion Therapeutics report earnings?

The next expected earnings date for Cyclerion Therapeutics is May 7, 2025

Should I buy Cyclerion Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page